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 Chapter 16 
 PBMC-Derived T Cells 
 Daniel  Lozano-Ojalvo ,  Rosina  López-Fandiño , and  Iván  López-Expósito 
 Abstract  T cell cultures are a valuable tool in food research to perform studies 
within the food allergy fi eld. Their main applications aim to analyze immunological 
responses towards food protein antigens to gain further insights into the mecha-
nisms responsible for the development of oral tolerance or for the triggering of food 
allergies. This chapter describes the main applications, isolation techniques, and 
culture conditions for PBMC-derived T cells. Furthermore, critical parameters of 
the model, together with the experimental read outs will be discussed. 
 Keywords  T cells cultures •  Food allergy •  Immunomagnetic cell isolation • 
 PBMCs  •  CD4 +  T cells 
16.1  Introduction and Origin 
 T lymphocytes or T cells are small (<10 μm) resting cells, which are generated in 
the bone marrow and migrate to the thymus where they become mature. Once 
matured, they enter the bloodstream and circulate to the secondary lymphoid organs, 
the sites of lymphocyte activation by the antigens. Actually, T cells are constantly 
recirculating between these organs until they encounter their specifi c antigen. Naïve 
T cells (T cells that have not yet met their specifi c antigen) bear antigen receptors 
specifi c for a single chemical structure, however lymphocytes in the body collec-
tively carry millions of different receptor specifi cities. Only those that meet an 
antigen to which their receptors bind will be activated to proliferate and differentiate 
into effector cells (Janeway et al.  2005 ). 
 This chapter deals with T lymphocytes derived from peripheral blood 
 mononuclear cells (PBMCs). T cells comprise, approximately, 45–70 % of PBMCs 
in human peripheral blood, with a count in healthy subjects in the range of 1 million 
cells/mL. For many years there was no function ascribed to these cells, until the 
1960s, when it gradually became apparent that T lymphocytes were the key mediators 
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of adaptive immunity. T cell cultures are a valuable tool in food research to perform 
studies within the food allergy fi eld. Their main applications aim to analyze 
immunological responses towards food protein antigens to gain further insights into 
the mechanisms responsible for the development of oral tolerance or for the trigger-
ing of food allergies (Martino et al.  2012 ). 
16.2  Features and Mechanisms 
 T cells express surface antigen receptors called T cell receptors (TCRs), which are 
inserted in the T cell surface and never secreted. The most common form is made up 
of α and β chains and it is found on about 95 % of circulating T cells. The TCR is a 
clonally distributed receptor, meaning that clones of T cells with different specifi cities 
express different TCRs. In the functional TCR, the α and β heterodimers are associ-
ated with a complex of four other invariant signaling chains, collectively called 
CD3, which are required for the cell-surface expression of the antigen binding 
chains and for signaling (Fig.  16.1 ) (Farber  2011 ). 
 There are two major types of T lymphocytes, classifi ed according to the 
expression of the cell surface co-receptors CD4 and CD8, which are proteins non- 
covalently associated with the TCR. Their function is to signal to the T cell that the 
TCR complex has bound the proper antigen. CD4 + T cells are generally referred as 
helper T cells or Th cells, because they secrete a multitude of cytokines that help or 
coordinate cellular and humoral immunity. CD8 + T cells are generally referred as 
cytotoxic T lymphocytes or Tc cells. Cytotoxic T cells recognize as antigens 
fragments of viral proteins on the surface of virus-infected cells, which they kill by 
the activation of a cascade of caspases. In humans, circulating CD4 + T cells out-
number CD8 + T cells by approximately 2:1 (Abbas et al.  2007 ). This chapter will 
deal with the CD4 + T lymphocytes, as they are the type of T lymphocytes that 
become activated during the allergic response. 
 T cell responses are initiated when a mature CD4 + T cell encounters a properly 
activated antigen presenting cell (APC), such as a dendritic cell, in a secondary 
 Fig. 16.1  TCR structural components (adapted from Farber  2011 ) 
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lymphoid organ. If the APC displays the appropriate peptide ligand through the 
major histocompatibility complex (MHC) class II molecule, it is recognized by the 
TCR. This is essential for activating a naïve T cell, but even if the co-receptor CD4 
is also ligated, for the T cell to proliferate and differentiate, two other stimulatory 
signals delivered by the APC are required. These signals are, on the one hand, the 
binding of two different ligands on the APC surface, designated as CD80 and CD86, 
to a surface molecule on the T cell, called CD28, and on the other, those involved in 
directing T cell differentiation into different subsets of effector T cells, the latter 
being mainly, but not exclusively, driven by cytokines, such as IL-6, IL-12 and 
TGF-β (Fig.  16.2 ). The CD28-dependent co-stimulation of activated T cells leads to 
production of IL-2 by the activated T cell themselves. Following expression of IL-2, 
there is also an upregulation of the third component (called α-chain) of the IL-2 
receptor, also known as CD25, in addition to other regulatory molecules such as 
ICOS and CD40L (Farber  2011 ). Binding of IL-2 to its high affi nity receptor pro-
motes cell growth, whilst APCs, mainly dendritic cells generate various cytokines 
or express surface proteins that induce the differentiation of CD4 + T lymphocytes 
into cytokine producing effector cells, depending on environmental conditions. 
 Originally, two main types of effector CD4 + T cells, called T-helper 1 ( Th1 ) and 
2 ( Th2 ) cells, were distinguished by the pattern of their cytokine secretion. Th1 cells 
secrete mainly IL-2, IFNγ and TNFα, and Th2 cells secrete IL-4, IL-13 and IL-5 
(Romagnani  2000 ). Recently, this view has been challenged by the discovery of a 
new lineage of T cells characterized by their ability to secrete a proinfl ammatory 
cytokine, IL-17, and thus designated Th17 cells. This new T cell type has been 
related with autoimmune diseases (Jing and Dong  2013 ). Another subset of antigen- 
driven CD4 + T cells, named regulatory T cells ( Treg ), acts by inhibiting T cell 
 Fig. 16.2  Signals involved in the activation of naïve T cells by APC 
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responses by the production of cytokines, such as IL10 and TGF-β and/or via 
cell–cell interactions (Jutel and Akdis  2011 ). Treg are CD4 + cells that also express 
the α-chain of the IL-2 receptor (CD25 + ) and the transcription factor FoxP3. 
 The immune response leading to food allergy is driven by two main groups of 
signals. The fi rst signal favors the differentiation of naïve T cells into a Th2 pheno-
type, and the second comprises the Th2 induced activation of B cells (mediated by 
cytokines such as IL-4 and IL-13 and co-stimulatory signals) to generate allergen- 
specifi c IgE antibodies (Mayorga et al.  2013 ). 
16.3  Applications of T Cell Cultures 
 The main application for T cell cultures is the  characterization of CD4  +   T cell 
epitopes from food allergens . The mapping of CD4 + T cell epitopes contributes to a 
better understanding of the pathophysiology of food allergy by enabling the identi-
fi cation of the major peptides that target allergen-specifi c T cells (Prickett et al. 
 2011 ,  2013 ). This requires the comparison of the epitope recognition patterns of a 
diverse and representative sample of allergic individuals, since a given T cell 
epitope elicits a signifi cant response only in subjects expressing MHC-class II 
molecules able to recognize and bind that particular epitope. In addition, the knowl-
edge of the sequence of T cell epitopes that stimulate CD4 + T lymphocyte responses 
allows the development of new forms of immunotherapy, which are safer and more 
effective than those using whole allergens. In this respect, peptide-based vaccines 
corresponding to T cell epitopes of the allergen of interest retain immunogenicity, 
but they are of insuffi cient length to cross-link allergen specifi c IgE on the surface 
of effector cells and elicit an allergic response (Worm et al.  2011 ). 
 Another important application related with the use of T cell cultures is the  study 
of the allergen - specifi c T cell responses during or after immunotherapy . In this 
context, evidence has accumulated that immunotherapy treatments shift a patient’s 
immune reaction to a specifi c allergen from a predominately allergic Th2 response 
to a Th1 response, while inducing Treg that downregulate Th2 and Th1-cells activity. 
The characterization of the frequency and phenotype of allergen-specifi c T cells is 
useful to understand the immunological changes subjacent to therapeutical inter-
ventions in allergic diseases (DeLong et al.  2011 ; Foster et al.  2011 ). In this context, 
the role of Treg producing IL-10 in allergen specifi c T cell tolerance and immune 
deviation has been studied by comparing the response of PBMCs and PBMCs 
depleted of CD25 + in patients undergoing immunotherapy, as well as in tolerant and 
allergic patients, allowing the identifi cation of potential markers that might be 
indicators of a favorable prognosis (Shreffl er et al.  2009 ; Bohle et al.  2007 ). 
Similarly, allergen-specifi c signaling can be assessed in activated and purifi ed CD4 + 
T cells to test whether there is a differential expression in the neonates who subse-
quently develop allergic diseases (Martino et al.  2012 ). 
 In the fi eld of food allergy, T cell gene and protein expression assays are very 
important for the understanding of the functional characteristics of allergen 
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reactive T cells. The use of PBMCs as a source of circulating T cells, that mimic 
effects occurring in remote target tissues of antigen exposure, presents the advantage 
that they can easily obtained by blood extraction and allow the study of parameters 
that otherwise would require more invasive methods, such a biopsy (de Mello et al. 
 2012 ). However, certain applications based on the exclusive employment of PBMC- 
derived T cells are limited because of the lack of APCs that are keys to the regula-
tion of the complicated set of mechanisms that determine the immune responses, as 
well as of other environmental infl uences that play an important role in shaping the 
APC functions. To overcome this limitation, there are other options, such as the use 
of co-cultures with APCs (Frischmeyer-Guerrerio et al.  2011 ; Hofmann et al.  2012 ) 
or complex culture systems with other cell types, such as APCs and intestinal epi-
thelial cells (Mileti et al.  2009 ). Another alternative are cell cultures from tissues of 
animal models of food allergy (spleen, lymph nodes, Peyer’s patches) (López- 
Expósito et al.  2011 ). In any case, and because of extension limits, this chapter will 
only deal with T cells that do not require APCs in the culture (more information 
available in Chap.  17 ). 
 Because of the low frequency of allergen-specifi c CD4 + T cells, several studies 
use allergen-specifi c CD4 + T cell lines or clones (Prickett et al.  2011 ,  2013 ), while 
others use primary CD4 + T cells, without addition of cytokines or repeated stimula-
tion (Frischmeyer-Guerrerio et al.  2011 ; Hofmann et al.  2012 ). Although T cell lines 
overcome the frequency limitation, previous in vitro expansion can alter cell pheno-
types or bias the results through the selection of the rapidly proliferating clones 
(Pascal et al.  2013 ). 
16.4  General Protocol 
16.4.1  T Cell Isolation Protocols 
 Because of the ease of access to peripheral blood, PBMCs, which contain T and B 
lymphocytes and monocytes, are the major source of human T cells used in most 
studies. There is a variety of available techniques for isolation and enrichment of T 
cells, including those based on their unique ability to bind and form rosettes with 
sheep red blood cells, as well as those based on differential adherence properties T 
cells to nylon wool. Despite their widespread use, the resulting T cell population is 
not very pure compared to the level of purity achieved with other procedures, and 
several reports suggest alterations in T cell functionality when these techniques are 
used (Wohler and Barnum  2009 ). 
 Human T cells can also be purifi ed on the basis of their cell-surface display if 
specifi c antigens can be recognized by monoclonal antibodies. This is currently 
carried out by two main methods: fl uorescence-activated cell sorting (FACS) and 
immunomagnetic cell separation (Martino et al.  2012 ; Prickett et al.  2013 ). FACS 
requires sophisticated technology, highly trained personnel; it is time consuming, 
expensive and may result in a signifi cant cell loss. Conversely, immunomagnetic 
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separation methods are faster, relatively inexpensive and do not require state of the 
art technology (Lancioni et al.  2009 ). 
 Immunomagnetic separation methods are based on the attachment of small 
magnetizable particles to cells via antibodies. The physical basis for such separation 
procedures involve the coupling of antibodies to magnetic beads, which subse-
quently allows the rapid capture of the cells specifi cally recognized by these anti-
bodies among a mixed population of cells placed in a magnetic fi eld. There are two 
types of magnetic cell isolation technologies, column and tube-based. Both work on 
the same principle, but the strength of the magnetic fi eld required is different 
because they use beads of different sizes. In particular, the  column - based technol-
ogy uses beads consisting of iron oxide and polysaccharide of, approximately 50 nm 
in diameter, which require a very strong magnetic fi eld. The main disadvantages of 
this system (exemplifi ed by MACS produced by Milteny Biotech) lay in its high 
initial and running costs, although it provides cells with high purity and optimal 
viability and functionality (Li et al.  2012 ). 
 The immunomagnetic  tube - based separation system utilizes micro-sized beads 
that can be selected using a magnet applied to a tube. The most commonly used 
beads, produced by Dynal, are 4.5 μm, uniform, spherical beads, which do not have 
any residual magnetism outside a magnetic fi eld. They consist of an iron-containing 
core surrounded by a thin polymer shell to which biomolecules may be adsorbed. 
These beads can be attached to cells via a coating of primary or secondary antibodies. 
The cells, surrounded by a “rosette” of beads, may then be separated from the unla-
beled population in a magnetic fi eld using a relatively small, but powerful magnet 
(Neurauter et al.  2006 ). 
 There are two main strategies for cell isolation using micro-sized beads:  positive 
and  negative selection . Positive selection can be performed using either direct or 
indirect approaches (Neurauter et al.  2006 ). Following  direct positive isolation , the 
appropriate antibody-coated beads are mixed with the sample and the target cells 
bound to the coated beads are subsequently collected with the aid of a magnet. For 
 indirect positive isolation , a cell population is exposed to saturating amounts of a 
primary antibody which binds to the target cells and, once the unbound antibodies 
are washed away, secondary-antibody coated beads bind to the primary antibodies 
on the surface of the target cells. For further functional applications, and in order to 
avoid modifi cations of the phenotype, the cells bound to antibody-coated beads 
should be detached by exposure to a soluble antiserum against Fab fragments (e.g., 
DETEACHaBEAD). However, surface bound antibodies may elicit the transmission 
of signals across the cell membrane. This can be avoided by negative isolation, 
which does not require attachment of antibodies to the cells of interest at any time 
(Neurauter et al.  2007 ). By  negative isolation , the cells are selected by removing all 
other cell types from the sample. Generally, a cocktail of monoclonal antibodies is 
incubated with the sample, followed by depletion of the undesirable cells using 
secondary antibody-coated beads (Biddison  1998 ; Mayer et al.  2013 ). Positive and 
negative separation strategies can be combined in the sequential sorting of T cell 
subsets, such as CD25 + FoxP3 + regulatory T cells, where depletion of unwanted cells 
is followed by positive selection of CD25 + T cell population (Mayer et al.  2013 ). 
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 The procedure described in this chapter is based on the indirect  positive isolation 
of a subset of human T cells relevant to food allergy, such as CD4 + T cells, by anti-
 CD4 and anti-IgG-coated beads (Biddison  1998 ; Neurauter et al.  2006 ). This 
methodology is very effi cient in removing target cells due to its fast cell capture 
kinetics, whereas the use of secondary-antibody coated beads makes it a fl exible 
protocol to isolate any cell of interest (Neurauter et al.  2007 ). 
16.4.2  Indirect Positive Isolation of Human CD4 + T 
16.4.2.1  Preparation of Cells and Antibodies 
 PBMCs could be obtained from whole blood by density gradient of Ficoll-Hypaque 
(Martino et al.  2012 ). It is convenient to determine the approximate number of CD4 + 
T cells in the starting population of PBMCs by fl ow cytometry using anti-CD4 
antibody. It is also helpful to establish the saturating concentration of anti-CD4 
mouse- IgG monoclonal antibody to be used by fl ow cytometry. Generally, 1 μg/mL 
per 1 × 10 6 cells works well as a saturating concentration. However, pretitration may 
allow the use of down to a tenfold lower concentration. 
16.4.2.2  Coating of PBMCs with CD4 Antibody 
 PBMCs (≤200 × 10 6 cells) are suspended in PBS/BSA and anti-CD4 mouse IgG 
antibody is added (10×). After incubation during 45 min at 4 °C with gentle tilting 
and rotation, cells are centrifuged 10 min at 600× g at room temperature. The super-
natant is discarded and the pellet resuspended in pre-cooled PBS/BSA. This step is 
repeated twice. Finally, washed cells are resuspended in 10 mL of pre-cooled PBS/
BSA and kept on ice for 15 min. 
16.4.2.3  Magnetic Beads Washing Procedure 
 On the basis of the number of CD4 + cells estimated by fl ow cytometry, the number 
of required goat anti-mouse IgG-coated magnetic beads is calculated. Five to ten 
magnetic beads are needed for each specifi c lymphocyte. Taking into account the 
concentration supplied by the manufacturer, the coated beads are resuspended in 
PBS and the desired volume of beads are transferred to a tube. PBS is added to the 
bead suspension and the tube is placed on a magnetic separation device for 2 min. 
The supernatant is then discarded by leaving the beads clinging to one side of the 
tube. The tube is removed from the magnet and the beads are washed following the 
previous step. Finally, the washed beads are resuspended in pre-cooled PBS/BSA 
and held on ice for 15 min. 
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16.4.2.4  Separation of T Cells 
 Anti-CD4-coated PBMCs are mixed with washed anti-IgG-coated beads and incu-
bated for 45 min at 2–8 °C with gentle tilting and rotation. Afterwards, the tubes are 
placed on a vertical magnet for 2 min and the supernatant is carefully discarded. 
It is important not to disturb the beads that are clinging to one side of the tube. Once 
the tube is removed from the magnet, the beads are gently resuspended in 5 mL of 
Lymphocyte Culture Medium (LCM), which contains RPMI-1640 medium, 2 mM 
 L -glutamine, 100 U/mL penicillin, 100 μg/mL streptomycin and 5 % (v/v) fetal 
bovine serum (FBS) (heat-inactivated during 1 h at 56 °C) (Prickett et al.  2013 ). 
Then, the tube is placed on the magnet for another 2 min and the non-collected cells 
aspirated, as in the previous step. The same procedure is repeated adding 5 mL of 
LCM to the tube. Finally, 2.5 mL of supernatant are carefully removed and the tube 
gently tapped to resuspend the T cells-coated-bead suspension. 
16.4.2.5  Detachment of T Cells from Beads 
 Polyclonal anti-mouse Fab antiserum (200 μL) is added. Approximately 10 μL of 
Fab antiserum are needed per 10 7 beads, although a smaller amount of Fab antise-
rum solution may be used when starting with smaller numbers of lymphocytes (see 
manufacturer’s instruction). This is mixed gently by tilting and rotation during an 
incubation period of 45–60 min at room temperature (incubation at 4 °C reduces the 
number of detached cells, while 37 °C does not increase detachment effi ciency). 
Due to the relatively small sample volume, care should be taken that the cells remain 
on the bottom of the tube during agitation. 5 mL of PBS/BSA are added to the tube 
to resuspend the beads. Tubes are placed on a vertical magnet for 2 min. The super-
natant containing the detached cells is then aspirated and left aside, while the beads 
remain attached to the wall of the tube by the magnet. It is important not to disturb 
the beads clinging to the side of the tube. This step is repeated four times to improve 
the isolation yield, saving and combining detached cell-containing supernatants 
from each separation in the same tube. Then, the tube with the detached T cells is 
centrifuged 10 min at 600× g at room temperature. The supernatant is discarded and 
the cells resuspended in LCM. Finally, T cells are counted and the number of viable 
cells determined by trypan blue exclusion. It is convenient to determine the purity 
of the CD4 + T cell population by fl ow cytometry using anti-CD4 antibody. 
16.5  Assess Viability 
 Once PBMC-derived T cells have been isolated and detached from the magnetic 
beads, they are usually resuspended in LCM (Prickett et al.  2013 ). Alternatively, 
Iscove’s modifi ed Dulbecco’s medium (IMDM), containing 100 U/mL penicillin, 
100 μg/mL streptomycin, 5 μg/mL gentamicin and 5 % of heat-inactivated FBS, 
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could also be used (Frischmeyer-Guerrerio et al.  2011 ). In the above proposed T cell 
culture media, FBS could be replaced by 5 % of heat-inactivated human serum or 
10 % heparinized human plasma. While most protocols use serum to provide opti-
mal conditions for T cell viability, reactivity and expansion, a number of serum-free 
media have been developed (e.g., AIM-V, Invitrogen Corporation; or X-VIVO, 
Lonza) (Shreffl er et al.  2009 ). These media are specifi cally formulated to support 
the culture of T cells and incorporate defi ned quantities of purifi ed growth factors, 
lipoproteins, and other proteins, which are usually provided by the serum. 
 Commonly, T cells are seeded at a fi nal concentration of 1–2.5 × 10 6 cells/mL in 
24 or 48-well cell culture plates (Pascal et al.  2013 ). Although, in T cell proliferation 
([H 3 ]-thymidine) and viability (MTT or XTT) assays, 96-well plates are used and 
only 100 μL of the cell solution are added, resulting in 1–2.5 × 10 5 cells per well (Martino 
et al.  2012 ). T cell culture assays are usually carried out in sample (three different 
wells) and biological triplicates (three different plates) (Prickett et al.  2011 ). 
 All incubations of T cell cultures must be performed at 37 °C in a humidifi ed 5 % 
CO 2 incubator. The incubation period for T cell assays varies depending on the ini-
tial cell population, percentage of damaged cells and stimuli used. Proliferation 
following mitogen-induced activation generally peaks after 2–6 days of culture 
(Bohle et al.  2007 ). An incubation period of 72 h is also used when proliferative 
responses to food proteins (such as OVA or peanut extracts) are studied (Prickett 
et al.  2011 ; Martino et al.  2012 ). However, for gene expression and cytokine 
detection assays, the response may not peak until after 5–10 days. Thus, the effect 
of Ara h 2 peptides has been analyzed after 4 days of incubation (Pascal et al.  2013 ), 
milk allergenic proteins after 5 days (Shreffl er et al.  2009 ) and Ara h 1 peptides after 
7 days (Prickett et al.  2013 ). To ensure that treatments do not affect cell health, a 
viability test should be performed. An array of methods and kit-based assays are 
available for cell viability, such as the measurement of mitochondrial reductase with 
tetrazolium salts (e.g. MTT, XTT and Alamar blue). 
16.6  Samples 
 Hydrophilic samples, such as polar food proteins, are usually added to the cells 
diluted in PBS or directly in the culture medium at different fi nal concentrations, 
which range from 10 to 200 μg/mL of culture (Pascal et al.  2013 ; Wing et al.  2003 ). 
When samples contain polyphenols or alcohols, they need to be resuspended in PBS 
or culture media containing 10 % of the aprotic and highly polar solvent 
DMSO. Potent T cell activators, such as mitogens (lectins like PHA or Concanavalin 
A), antigens (tetanus toxoid) or antibodies (anti-CD3/CD28) should be included as 
positive controls in the assays to test both cell viability and functionality (Bohle 
et al.  2007 ; Pascal et al.  2013 ). 
 A critical parameter in the evaluation of the response to proteins of T cells is 
sample quality. This is crucial for recombinant proteins which are produced in 
bacterial systems. These can carry over contaminants from the host cells to the fi nal 
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recombinant preparation, including irrelevant proteins and lipopolysaccharide 
(LPS). LPS, synthesized by gram-negative bacteria, has profound effects on T cell 
responses. LPS drives the development of Th1 subsets and it is also associated with 
toxicity (McAleer and Vella  2008 ). Because of these reasons, the purity of the 
proteins, and particularly the LPS concentration, should be determined by available 
commercial kits before application to T cell assays (Hofmann et al.  2012 ). 
16.7  Experimental Readouts 
 In vitro T cell functional measures to stimuli may be monitored by assays that detect 
proliferation, cytokine secretion and the expression of genes of interest, or charac-
terizing proliferating cells to identify phenotype and frequency. Measurement of the 
proliferative responses of T cells is fundamental for the assessment of their biologi-
cal reaction to various stimuli, such as food allergens or hypoallergenic prepara-
tions. T cell proliferation is commonly determined by estimating incorporation of 
[H 3 ]-thymidine into the DNA, a process which is closely related to underlying 
changes in cell number. [H 3 ]-thymidine methodology has been widely utilized in 
allergen-specifi c T cell proliferation studies (Prickett et al.  2011 ; Shreffl er et al. 
 2009 ). Alternatively, carboxyfl uorescein diacetate succinimidyl ester (CFSE) 
labeling prior to T cell culture enables direct measurement of cell division and it 
may be used in combination with cell surface markers to identify the target cells by 
fl ow cytometry (Foster et al.  2011 ; Prickett et al.  2013 ). 
 Cytokine secretion in response to a stimulus may be detected by measuring either 
cytokine production (by ELISA) or enumerating individual cytokine producing T 
cells (by ELISPOT). ELISA has been used to evaluate T cell behavior towards food 
allergens in several studies (Glaspole et al.  2011 ; Hofmann et al.  2012 ). In contrast 
to ELISA, ELISPOT allows the visualization of the secretory products of individual 
activated or responding T cells. Thus, it provides both qualitative (kind of cytokine) 
and quantitative (number of antigen-specifi c T cells) information (Prickett et al. 
 2011 ; Faresjö  2012 ). Flow cytometry has been also used for the measurement of T 
cell cytokine production by fl uorescent bead arrays (e.g., Cytometric Bead 
Array™—CBA, BD Biosciences) (Kücüksezer et al.  2013 ; Pascal et al.  2013 ). Flow 
cytometry can also be used for phenotypic analysis of T cell subsets, frequency 
determination (Shreffl er et al.  2009 ; Hofmann et al.  2012 ) and detection of intracel-
lular cytokines (DeLong et al.  2011 ). Finally, Real-Time quantitative PCR 
(RT-qPCR) has been largely used for the study the expression of cytokine genes 
(Kücüksezer et al.  2013 ). Gene expression has also been assessed in purifi ed CD4 + 
T cells by DNA microarrays to characterize T cell signaling pathways of allergic 
and non allergic children (Martino et al.  2012 ). 
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